Sonic GP LLC's Q1 2023 13F: 2 positions resized, no new positions or exits

Form 13F-HR for the quarter ended Mar 31, 2023 · filed May 15, 2023 · 25 reported positions · accession 0001013594-23-000475

What changed this quarter

Sonic GP LLC's changes in reported equity positions, Q1 2023
Activity Security Weight before Weight now Change Shares Shares %
Reduced GENWORTH FINL INC (GNW) 5.3% 3.2% −2.1 pts −500K sh −37%
Reduced ADVERUM BIOTECHNOLOGIES INC (ADVM) 2.0% 1.1% −0.9 pts −2.55M sh −56%

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 72.1% of the equity book

Changes in the top 10 this quarter: RDN entered · GNW left

# Security Weight before Weight now
1 FENNEC PHARMACEUTICALS INC (FENC) 17.3% 15.3%
2 SPIRIT AIRLS INC (SAVEQ) 8.8% 7.9%
3 ALGOMA STL GROUP INC (ASTL) 5.7% 7.4%
4 SEAWORLD ENTMT INC (PRKS) 6.0% 7.0%
5 BRIGHTHOUSE FINANCIAL, INC. CMN (BHF) 7.7% 6.7%
6 UNITED STATES STL CORP NEW (X) 5.6% 6.0%
7 UNITED AIRLS HLDGS INC (UAL) 4.9% 5.8%
8 US FOODS HLDG CORP (USFD) 5.1% 5.6%
9 CEDAR FAIR L P (FUN) 4.7% 5.2%
10 RADIAN GROUP INC (RDN) 4.3% 5.1% Entered the top 10
— GENWORTH FINL INC (GNW) 5.3% 3.2% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).